Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
42. Schiff R, Massarweh S, Shou J, Osborne CK 2003 Breast cancer endocrine<br />
resistance: how growth factor signaling and estrogen receptor coregulators<br />
modulate response. Clin Cancer Res 9:447S-54S<br />
43. Graham JD, Bain DL, Richer JK, Jackson TA, Tung L, Horwitz KB 2000<br />
Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast<br />
cancer. Steroids 65:579-84<br />
44. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec<br />
G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K,<br />
Katzenellenbogen JA 2000 Estrogen receptors: selective ligands, partners, and<br />
distinctive pharmacology. Recent Prog Horm Res 55:163-93; discussion 194-5<br />
45. Smith CL, Nawaz Z, O'Malley BW 1997 Coactivator and corepressor regulation<br />
of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.<br />
Mol Endocrinol 11:657-66<br />
46. Kirkegaard T, McGlynn LM, Campbell FM, Muller S, Tovey SM, Dunne B,<br />
Nielsen KV, Cooke TG, Bartlett JM 2007 Amplified in breast cancer 1 in<br />
human epidermal growth factor receptor - positive tumors of tamoxifen-treated<br />
breast cancer patients. Clin Cancer Res 13:1405-11<br />
47. Ray P, Ghosh SK, Zhang DH, Ray A 1997 Repression of interleukin-6 gene<br />
expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the<br />
transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS<br />
Lett 409:79-85<br />
48. Safe S 2001 Transcriptional activation of genes by 17 beta-estradiol through<br />
estrogen receptor-Sp1 interactions. Vitam Horm 62:231-52<br />
47
Change language